IVD Market to Cross US$ 70 Billion by 2017

Press release   •   Apr 12, 2013 12:06 IST

As per a new research report by RNCOS, “In Vitro Diagnostic Market Analysis to 2017”, the In-Vitro Diagnostics (IVD) Industry represents one of the most lucrative segments in the global Healthcare Industry. The size of the global IVD market was in excess of US$ 52 Billion in 2012 and is expected to rise at a CAGR of 7% during 2012-2017. This augmentation is expected to sustain in the future on the back of several factors, such as rising percentage of aged population and increasing prevalence of chronic diseases.

In the report, the IVD market has been studied on three distinct levels: Regional, Clinical Segment, and Company. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Further, the market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2017 has been analyzed. This has helped our analysts to clearly identify and highlight the clinical segments that offer the maximum opportunity for growth in each region.

The study further delves into the business dynamics of the major players in industry. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, our team has also analyzed each company’s strengths and weaknesses along with their recent industrial activities. This will help the reader to gain a deeper insight into each key market player.

The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. It facilitates the future forecasts on the total IVD market, clinical segments and regional markets. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.